Minglu Liu

机构：Beijing University of Chinese Medicine, Dalian Medical University

发表论文 12 篇 · 总被引 89 次 · h-index 4

代表论文

• Combining network pharmacology, machine learning, molecular docking and molecular dynamic to explore the mechanism of Chufeng Qingpi decoction in treating schistosomiasis (2024 · Frontiers in Cellular and Infection Microbiology · 被引 38)
• TP53 R273C Mutation Is Associated With Poor Prognosis in LGG Patients (2022 · Frontiers in Genetics · 被引 30)
• Tumor-derived DEFB1 induces immune tolerance by inhibiting maturation of dendritic cell and impairing CD8+ T cell function in esophageal squamous cell carcinoma (2024 · Chinese Journal of Cancer Research · 被引 5)
• Pattern recognition receptors and their roles in antiviral innate immunity in livestock (2026 · Frontiers in Immunology · 被引 4)
• Predictive Biomarkers of Dicycloplatin Resistance or Susceptibility in Prostate Cancer (2021 · Frontiers in Genetics · 被引 4)
• Short‑term efficacy assessment of brigatinib for the treatment of neurofibromatosis type 2: A retrospective study (2025 · Oncology Letters · 被引 2)